5-hydroxy-2-n,n-dipropylaminotetralin has been researched along with way 100135 in 1 studies
| Studies (5-hydroxy-2-n,n-dipropylaminotetralin) | Trials (5-hydroxy-2-n,n-dipropylaminotetralin) | Recent Studies (post-2010) (5-hydroxy-2-n,n-dipropylaminotetralin) | Studies (way 100135) | Trials (way 100135) | Recent Studies (post-2010) (way 100135) |
|---|---|---|---|---|---|
| 42 | 0 | 3 | 143 | 0 | 34 |
| Protein | Taxonomy | 5-hydroxy-2-n,n-dipropylaminotetralin (IC50) | way 100135 (IC50) |
|---|---|---|---|
| Angiotensin-converting enzyme | Homo sapiens (human) | 0.0339 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 1.491 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.0339 | |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 1.491 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 1.491 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lima, L; Schmeer, C; Urbina, M | 1 |
1 other study(ies) available for 5-hydroxy-2-n,n-dipropylaminotetralin and way 100135
| Article | Year |
|---|---|
5HT1A receptor agonist differentially increases cyclic AMP concentration in intact and lesioned goldfish retina. In vitro inhibition of outgrowth by forskolin.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adenylyl Cyclases; Animals; Cells, Cultured; Colforsin; Cyclic AMP; Dopamine Antagonists; Goldfish; Nerve Crush; Nerve Regeneration; Optic Nerve; Piperazines; Retina; Serotonin Antagonists; Serotonin Receptor Agonists | 1996 |